NIH Guide for Grants and Contracts
June 28, 2019
Weekly NIH Funding Opportunities and Notices

General Notices

Notice of Changes to Funding Opportunities

Funding Opportunities

  • Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)
    (PAR-19-301)
    National Institute of General Medical Sciences
    Application Receipt Date(s): September 26, 2019; June 15, 2020; June 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
    (PAR-19-302)
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2019.

  • Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional)
    (PAR-19-304)
    National Institute on Aging
    Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 16, 2019.

  • Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)
    (PAR-19-305)
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 16, 2019.

  • FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
    (PAR-19-306)
    Food and Drug Administration
    Application Receipt Date(s): October 11, 2019 by 11:59 PM Eastern Time. April 13, 2020 and October 13, 2020 by 11:59 PM Eastern Time. April 12, 2021 and October 12, 2021 by 11:59 PM Eastern Time. April 12, 2022 and October 11, 2022 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.

  • Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)
    (PAR-19-307)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): January 14, 2020, January 14, 2021, and January 14, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)
    (PAR-19-309)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 1?6, 2019.

  • Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional)
    (PAR-19-310)
    National Institute on Drug Abuse
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Transition to Aging Research for Predoctoral Students (F99/K00)
    (RFA-AG-20-009)
    National Institute on Aging
    Application Receipt Date(s): October 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
    (RFA-AG-20-018)
    National Institute on Aging
    Application Receipt Date(s): October 2, 2019, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this funding opportunity announcement.

  • Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)
    (RFA-AG-20-020)
    National Institute on Aging
    Application Receipt Date(s): October 21, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
    (RFA-AG-20-021)
    National Institute on Aging
    Application Receipt Date(s): October 22, 2019, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement.

  • Science of Behavior Change (SOBC) Resource and Coordinating Center (U24 Clinical Trial Not Allowed)
    (RFA-AG-20-024)
    National Institute on Aging
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): October 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional)
    (RFA-AG-20-028)
    National Institute on Aging
    Application Receipt Date(s): October 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this funding opportunity announcement.

  • Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed)
    (RFA-AG-20-039)
    National Institute on Aging
    Application Receipt Date(s): February 3, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this funding opportunity announcement.

  • Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R21 Clinical Trial Not Allowed)
    (RFA-AG-20-041)
    National Institute on Aging
    Application Receipt Date(s): October 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01 Clinical Trial Not Allowed)
    (RFA-AG-20-042)
    National Institute on Aging
    Application Receipt Date(s): October 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.

  • Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
    (RFA-CA-19-031)
    National Cancer Institute
    Application Receipt Date(s): August 29, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trial Not Allowed)
    (RFA-CA-19-055)
    National Cancer Institute
    Application Receipt Date(s): August 30, 2019 All applications are due by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)
    (RFA-DA-20-008)
    National Institute on Drug Abuse
    Application Receipt Date(s): November 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed)
    (RFA-DA-20-009)
    National Institute on Drug Abuse
    Application Receipt Date(s): November 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Development of Clinical Outcome Assessments for Clinical Trials in Substance Use Disorders as FDA-qualified Drug Development Tools (U01 Clinical Trial Optional)
    (RFA-DA-20-015)
    National Institute on Drug Abuse
    Application Receipt Date(s): October 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed)
    (RFA-EB-19-001)
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): September 3, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial not allowed)
    (RFA-EB-19-002)
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 3, 2019, September 3, 2020, and September 3, 2021 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed)
    (RFA-MH-20-145)
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Neurological Disorders and Stroke
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): October 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

  • BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed)
    (RFA-MH-20-150)
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Neurological Disorders and Stroke
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): October 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed)
    (RFA-MH-20-300)
    National Institute of Mental Health
    Application Receipt Date(s): September 3 July 1 , 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

  • BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01 Clinical Trial Optional)
    (RFA-MH-20-310)
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 03, 2019 and February 14, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

  • NINDS Child Neurologist Career Development Program (CNCDP) (K12 Clinical Trial Not Allowed)
    (RFA-NS-19-040)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.